Albin Österroos

8PUBLICATIONS
52CO-AUTHORS
Gene and molecular therapyHaematological tumoursMedical molecular engineering of nucleic acids and proteinsDevelopmental genetics (incl. sex determination)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 23, 2026
Patient-tailored azacitidine, venetoclax and gilteritinib triplet therapy appear to improve tolerability while preserving encouraging clinical outcomes in FLT3-mutated relapsed/refractory AML.

|Jul 08, 2026
Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemia.

|Feb 19, 2024
Delineating functional and molecular impact of ex vivo sample handling in precision medicine.

Nona Struyf, Albin Österroos, Mattias Vesterlund

|Apr 06, 2023
Somatic Exonic Deletions in RUNX1 Constitutes a Novel Recurrent Genomic Abnormality in Acute Myeloid Leukemia.

Anna Eriksson, Marie Engvall, Lucy Mathot

|Mar 25, 2023
Prediction model for drug response of acute myeloid leukemia patients.

Quang Thinh Trac, Yudi Pawitan, Tian Mou

|Jun 13, 2020
Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemia.

Albin Österroos, My Björklund, Anna Eriksson

Pageof 2

Frequent Collaborators

3 joint publications

Panagiotis Baliakas

2 joint publications

Vladimir Lazarevic

2 joint publications

Christer Nilsson

2 joint publications

Mattias Vesterlund